Aires Inês, Fila Marc, Polidori David, Santos Ana Rita, Costa Ana Brito, Calado Joaquim
Department of Nephrology, Hospital de Curry Cabral - CHLC, Lisbon, Portugal.
Nephron. 2015;129(4):300-4. doi: 10.1159/000381677. Epub 2015 Apr 18.
BACKGROUND/AIMS: Familial Renal Glucosuria (FRG) is characterized by the presence of persistent isolated glucosuria in the absence of hyperglycemia. Mutations in SLC5A2, the gene coding for the sodium-glucose co-transporter 2 (SGLT2), are responsible for FRG. Phenotype/genotype correlations in FRG have mostly relied on the quantification of Urinary Glucose Excretion (UGE), which is dependent on both the filtered glucose load and the renal glucose reabsorptive capacity. In the current work, the renal threshold for glucose excretion (RTG) was determined in an FRG cohort, with the purpose of characterizing the impact of SGLT2 mutations on renal glucose transport.
From January to December of 2013, eight FRG individuals with identified SLC5A2 mutations were enrolled. Patients were given a Mixed-Meal Tolerance Test during which blood glucose and UGE were measured over a 4 h period and the data was used to calculate RTG, according to a recently validated protocol.
In patients with homozygous mutations, RTG values were very low, with a mean (SD) of 0.95 (1.17) mmol/l, compared to commonly reported values of approximately 10-11.1 mmol/l in healthy subjects. In subjects with heterozygous mutations, mean (SD) RTG values were 4.91 (1.23) mmol/l, which are approximately one-half of the values in subjects without mutations.
In FRG, mutations in SLC5A2 lead to reductions in RTG and increases in UGE. Because determination of RTG is not influenced by the filtered glucose load, the calculated RTG values provide a more refined measure of the impact of mutations on renal glucose transport than can be obtained from UGE alone.
背景/目的:家族性肾性糖尿(FRG)的特征是在无高血糖的情况下存在持续性孤立性糖尿。编码钠-葡萄糖协同转运蛋白2(SGLT2)的基因SLC5A2发生突变是导致FRG的原因。FRG中的表型/基因型相关性大多依赖于尿葡萄糖排泄量(UGE)的量化,而UGE既取决于滤过的葡萄糖负荷,也取决于肾脏的葡萄糖重吸收能力。在当前研究中,我们在一个FRG队列中测定了葡萄糖排泄肾阈值(RTG),目的是描述SGLT2突变对肾脏葡萄糖转运的影响。
2013年1月至12月,招募了8名已鉴定出SLC5A2突变的FRG患者。患者接受了混合餐耐量试验,在此期间测量了4小时内的血糖和UGE,并根据最近验证的方案用这些数据计算RTG。
在纯合突变患者中,RTG值非常低,平均(标准差)为0.95(1.17)mmol/l,而健康受试者通常报告的值约为10 - 11.1 mmol/l。在杂合突变受试者中,平均(标准差)RTG值为4.91(1.23)mmol/l,约为无突变受试者值的一半。
在FRG中,SLC5A2突变导致RTG降低和UGE增加。由于RTG的测定不受滤过葡萄糖负荷的影响,因此计算出的RTG值比仅从UGE获得的结果能更精确地衡量突变对肾脏葡萄糖转运的影响。